Empo Health exists to empower diabetic patients and their providers to improve care, outcomes, and quality of life through innovative in-home health monitoring solutions.

Empo Health addresses the significant healthcare challenge of diabetic foot ulcers (DFUs) which affect 25% of diabetic patients in their lifetime and lead to 150,000 amputations yearly in the US, costing over $80 billion annually. Their FDA-listed Empo Footprint in-home imaging scale combined with the Empo Remote Health Link patient monitoring service enables near-daily imaging and clinician review. This technology helps detect early signs of diabetic foot ulcers to intervene at the right time, reducing hospitalizations, amputations, and improving patients' quality of life.

The solution is practical and routine for providers and easy for patients, allowing regular in-home foot monitoring to identify issues early and coordinate care effectively. Empo Health was founded in 2020 by MIT- and Stanford-trained technical founders and is based in the San Francisco Bay Area.